OVERVIEW

Interventional Pulmonology in Cancer Patients: Advanced Bronchoscopy and Lung Cancer is organized by The University of Texas MD Anderson Cancer Center and will be held on Mar 27, 2026 at Mitchell Research Building, Houston, Texas, United States of America.

Description:
The integration of robotic bronchoscopy and mobile cone-beam CT guidance is transforming lung cancer diagnosis and staging. This activity will address how these technologies enable clinicians to safely and efficiently access small peripheral lung nodules and obtain high-quality tissue samples suitable for molecular profiling, all within a single procedure that includes mediastinal staging. This 2-day course offers an immersive, hands-on experience designed to enhance diagnostic accuracy and procedural safety during navigational bronchoscopy. Participants will receive practical training in advanced endobronchial ultrasound (EBUS) techniques, including transbronchial cryobiopsy and core lymph node biopsies. Whether you're an experienced practitioner or expanding your expertise, this program equips you with the skills needed to apply the latest innovations in interventional pulmonology and elevate patient care.

Objectives:
At the conclusion of this activity, learners will be able to:

  • Utilize appropriate lung cancer screening techniques according to national guidelines and standards.
  • Assimilate therapeutic options for the management of airway tumors.
  • Interpret available evidence for adjunctive therapies in the palliative and curative management of lung cancer.
  • Apply principles of evidence-based medicine in evaluating new technologies.
  • Demonstrate the ability to perform Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration on a porcine model.
  • Perform endobronchial stenting on a porcine model.
  • Incorporate evidence-based best practices for the management of recurrent malignant pleural effusions.

KEY DATES

Event Start Date
27 Mar, 2026
Event Start Date
Event End Date
27 Mar, 2026
Event End Date
Credits

Accreditation
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

  • 13.75 AMA PRA Category 1
  • 13.75 MOC
  • TARGET AUDIENCE

    PhysicianPulmonologists

    SPECIALITIES

    Pulmonary DiseaseOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationMitchell Research Building
    6767 Bertner Ave

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45

    Oct 29 - 30, 2026 | Orlando, Florida, USA

    Oncology
    More actions
    US$235